Researchers found that a measure called phenotypic age acceleration (PhenoAgeAccel) is linked to increased risks of heart disease and mortality. This study analyzed data from over 31,000 participants in the UK Biobank, revealing that higher PhenoAgeAccel scores correlate with a greater likelihood of developing cardiovascular disease (CVD), ischemic heart disease, heart failure, and even dying from these conditions. Specifically, each standard deviation increase in PhenoAgeAccel—equivalent to about 4.6 years—was associated with significant increases in risk, particularly among women.

This discovery is crucial for anyone interested in aging well and maintaining heart health. If you want to reduce your risk of heart disease and improve your longevity, understanding your PhenoAgeAccel could be important. The study suggests that as your biological age accelerates, your heart may not function as well, leading to adverse changes in heart structure and function. By addressing factors that contribute to cardiac remodeling and improving metabolic health, you might counteract some of the risks associated with accelerated aging.

The research is based on a large-scale analysis, providing strong evidence of the relationship between PhenoAgeAccel and cardiovascular outcomes. However, while the findings are compelling, they are observational and do not prove causation. The study highlights the importance of monitoring biological aging and its potential impact on heart health, suggesting that lifestyle changes aimed at improving heart function could help mitigate these risks.

Source: academic.oup.com